Company intelligence / Profile preview

Semorex Technologies

Rehovot, Shfella Area, Israelfinder.startupnationcentral.org ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has discovered molecular compounds with potent and selective anticancer activity against solid tumors and hematological malignancies[2][4]. Their lead candidate SEM-007 is in preclinical development for neoplasms[5].

Therapeutic areas: OncologyGastroenterology
Modalities: Small molecule drugsChemiluminescent agents
Industry: Biotech

Beyond the preview

Go deeper on Semorex Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semorex Technologies.

Explore the full profile